Episodios
-
(This episode originally aired on September 26, 2023.)
Value-based care has been dominating industry conversations in recent years. Here on Radio Advisory, we talk a lot about best practices, how to make the right investments, and how to best prepare leaders for the future of value-based care. But given all this momentum, we want to spend time asking the question: what are the misconceptions or misaligned expectations that leaders have around value-based care?
In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care expert Daniel Kuzmanovich and Optum Advisory Service's SVP of value-based care, Erik Johnson, to discuss the mindset shifts they think leaders should be making when pursuing a sustainable value-based care strategy. Throughout the conversation they discuss what leaders are currently getting wrong, how myths about value-based care are impacting the industry, and more.
Links:
Our Value-based Care playlistEp. 172: Build a value-based enterprise: Live from 2023 Value-Based Care SummitEp. 126: [Bonus content] Commercial risk is possibleâhere's howHow Health Plans Can Support Providers in RiskThe climb to value-based care3 strategies for a successful sleep apnea therapy program: Lessons from ENTTX's ASC partnership
Strategic Planner's survey 2024
Survey insights: 6 priorities for health system strategists in 2024
Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.
-
In the last few years, all eyes have turned to GLP-1s as an industry-altering answer to obesity treatment and weight management. But the fact is, these drugs canât â and shouldnât â work in a vacuum. There is a fear that attention on GLP-1s may even blind leaders to the other services that go into providing effective obesity care. So, what should leaders be thinking about when designing and and delivering effective obesity care?
To answer that question, host Abby Burns invites Advisory Board experts Chloe Bakst, Payton Grimes, and Atticus Raasch to unpack what comprehensive weight management programs look like in practice, and whyâif done wellâ they can benefit patients, clinicians, and health systems.
Links:
4 key elements of comprehensive obesity care (and how they look in practice)How 3 health systems provide comprehensive care for obesityEp. 181: Does healthcare's approach to obesity harm patients?Ep. 159: Ozempic, Wegovy, and our questions on weight management drugsLearn more about On-demand Courses
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
-
¿Faltan episodios?
-
When we talk about âhealth systems,â it can sound like weâre talking about a monolith. But in reality, the $1.4 trillion dollar health system sector is made up of a diverse range of players. Academics and safety nets; urban and rural systems; 1,000-bed systems and 25-bed critical access hospitals. The question is, especially as systems emerge from the financial hardships of the past few years, how do those differences translate to the ways systems are running at growth?
In this episode, the third and final installment in our series leading up to Advisory Boardâs Strategy Summit, host Abby Burns invites Advisory Board health system experts Elizabeth Orr and Marisa Nives to unpack how leaders across the health system sector are thinking differently about growing in 2025 and beyond.
Links:
Hospitals' top strategic priorities â and what they mean for development leadersEp. 220: Why AI in healthcare is more than just ChatGPTEp. 219: The business case for going greenEp. 218: [Encore + bonus content] Site-of-care shifts: It's time to go on offenseCharted: The financial gap between rich and poor hospitals growsJoin us at the Pivots for a Sustainable Future Summit on September 10-11, 2024.
Learn about Advisory Board Fellowship
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
-
Weâve talked a lot about AI on Radio Advisory, with a particular emphasis on generative models and their capabilities. But are there other models of AI that are flying under the radar? Todayâs episode focuses on computer vision and its potential to shift how we think about the use of technology in healthcare.
For the second episode in our series leading up to Advisory Boardâs upcoming Strategy Summit, host Abby Burns invites digital health experts Ty Aderhold and Elysia Culver to break down why computer vision should be on our minds, arguably just as much as generative AI.
Links:
Ep. 185: AI adoption: why you can't afford to "wait and see"10 ways computer vision can transform the future of healthcareComputer vision in healthcareJoin us at the Pivots for a Sustainable Future Summit on September 10-11, 2024.
Register for the How to harness the potential of digital experience in healthcare webinar on September 17.
Learn more about Advisory Board Sponsorship.
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
-
It's no secret that climate change has had a massive effect on population health, but itâs also impacting healthcare business. Did you know that energy costs have gone up by 28% in the past five years? Health systems in particular can shave percentage points off their annual costs by reducing their energy consumptionâbut there is both a knowledge gap and an action gap keeping leaders from taking advantage of the opportunity.
Advisory Boardâs Strategy Summit on September 10-11 is all about the pivots health systems need to make for a sustainable future â no better way to kick off our lead-up to the event than by taking that quite literally and talking about environmental sustainability.
In this episode, host Abby Burns invites Advisory Board expert Miles Cottier to break down how and why health business leaders need to prioritize environmental sustainability. They explore the financial case for moving to renewable energy sources, how regulatory pressures may (or may not) shape the future of environmental action, and what leaders can do today to support their green initiatives.
Links:
Green financing for health systemsClimate change is affecting heart health. Hereâs what you can do.Ep. 119: How health leaders can address climate changeEp. 164: Boston Medical Center's path to sustainability (and how they're funding it)Join us at the Pivots for a Sustainable Future Summit on September 10-11, 2024
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
-
This week, host Abby Burns invites Advisory Board expert Sebastian Beckmann back to Radio Advisory to provide an updateâas promisedâon what his team has uncovered about site-of-care shifts in the six months since he first brought this research to the pod. Hint: thereâs about $50B at play.
This episode is a modified encore of Episode 195: Site-of-care shifts: Itâs time to go on offense.â In that episode, Sebastian and fellow Advisory Board expert Nick Hula joined Abby to break down how health systems should be thinking about site-of-care shifts as a part of their growth strategies, including making the transition from a âdefensiveâ mindset to prevent volume shifts, to an âoffensiveâ mindset to capture them.
The original episode will play almost in its entirety, with interjections from Abby and Sebastian to dig deeper into what the site-of-care shift opportunityâor riskâactually looks like across markets and services.
Links:
Seize the $50 billion site-of-care shift opportunityInteractive maps: See where site-of-care shifts are having the biggest impactSite-of-care shifts: Healthcareâs $50B opportunityYour guides to volume growth in 6 key service lines4 takeaways from our updated provider volume forecast5 trends (re)shaping site-of-care shiftsWhatâs happening with joint replacement volumes?Ep. 193: Is health system growth still possible?Learn more about On-demand Courses
Use the Market Scenario Planner
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
-
(This episode originally aired on September 12, 2023.)
With rising costs and tightening margins, the industry is continually looking for ways to "bend the cost curve" while maintaining, or even increasing, quality and performance. One stakeholder in particular, employers, are feeling significant pressures from inflation, hospital consolidation, the rise of high-cost drugs, and more. While many legacy cost-saving strategies have focused on reducing employer costs, it may be time to shift focus to lowering costs for employees as well.
In this episode, host Rachel (Rae) Woods invites Advisory Board payer expert Max Hakanson and Innovation lead at JPMorgan's Morgan Health Rivka Friedman to discuss what employers can do to rein in healthcare costs, both for themselves and their employees. Throughout the discussion, they discuss why legacy cost-sharing strategies may be insufficient, and what new innovations are showing promise in the market.
Links:
Home | Morgan HealthEp. 165: Employer series: Is the cost of employer-sponsored insurance unsustainable?Investigating the high costs in employer-sponsored insurance5 health benefits strategies for self-funded employers3 things to know about ESI (that you won't find in a benefits survey)Learn more about Advisory Board Sponsorship
-
(This episode originally aired on March 12, 2024.)
The relationship between health plans and providers has always included an element of friction, but lately, it seems like the temperature is rising. And you've probably noticed â public contracting disputes increased by 69% between 2022 and 2023.
That's why, in this episode, host Abby Burns invites Advisory Board experts Max Hakanson and Eileen Fennell to discuss why the state of affairs seems to be getting worse, how key flashpoints are fanning the flames, and what each stakeholder says they need to see from their partners in order to mend the relationship. Plus, Advisory Board digital health expert Ty Aderhold makes a cameo appearance to help answer the question: Is AI the solution here?
Links:
7 things we want to fix in 2024 (and how to get there)A new era of payer-provider relationshipsThe new era of provider enablementAI in healthcare: Insights from 10 C-suite executivesLearn about the Advisory Board Fellowship
-
Healthcare leaders have dozens of priorities on their plates, and achieving innovation is not as simple as just buying a new technology or implementing a new care model. Frankly, it can be overwhelming not just to see innovations through, but even to get started. So, what does it really take to innovate? And how do you align your organizationâs challenges with the solutions or innovations that are being presented to you?
In this special episode, live from Advisory Boardâs 2024 Clinical Innovation Summit, guest host and Advisory Board digital health expert John League invites Dr. Ayo Ajaiyeoba from Blue Cross Blue Shield of Kansas City, and Elliot Green, cofounder and CEO of Dandelion Health, to dive deep on the realities of innovation. Throughout the discussion, they explore what it takes to get started, how to act in the face of ambiguity, and how you should be thinking about tools like data and partnerships to achieve your goals.
Links:
Blue Cross Blue ShieldDandelion HealthTop 5 takeaways from our Clinical Innovation Summit4 imperatives for the future of healthcare innovationTruly personalized care is possible. Here's how to make it a reality.More upcoming events from Advisory Board
Learn more about Advisory Board On-Demand Courses
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
It seems like a no-brainer for healthcare organizations to allocate time and attention to a health condition that is guaranteed to affect 50% of adults during their midlife yearsâbut that hasnât been the case.
Weâre seeing momentum around making menopause mainstreamâfrom the White House directing research funding, to Hollywood stars talking openly about menopause, to the rise of femtech companies geared toward helping consumers navigate the clinical and social effects of menopause. But though 100% of women in midlife will experience this clinical event, the reality is that most womenâs health programs are primarily focused on what our guests have referred to in the past as the âbikini approachâ to womenâs health, and have largely ignored the needs of women in the post-reproductive years. From a clinical and financial standpoint, this is a missed opportunity. And given 80% of the healthcare workforce is women, and one-third of those women are in midlife, itâs also a competitive vulnerability.
Thatâs why this week, host Rachel (Rae) Woods invites Advisory Board womenâs health experts Kara Marlatt and Gaby Marmolejos to explore how provider and employer leaders can build systems that account for and address womenâs health needs âbeyond the bikini.â
Links:
5 ways employers can support women's health during midlifeFive women leaders on the shifting landscape of women's health, per UnitedHealthcare (beckerspayer.com)Ep. 188: The business case for investing in women's healthThe business case for investing in womenâs specialty careWomenâs health opportunity: Menopause symptom care[Webinar, Aug. 13] Your guide to the lab and diagnostics market landscape in 2024
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
In recent years, weâve seen large retailers like CVS, Walgreens, Walmart, and even Amazon add to their care delivery portfolios, specifically through offering low-acuity primary care services. But it seems like the tide may be shifting. In April, Walmart announced that itâs shuttering its primary care operations and virtual care armâand itâs not the only one scaling back. The fact is, a number of retailers are retrenching on primary care operations.
In this episode, host Abby Burns invites Advisory Board experts Vidal Seegobin, Natalie Trebes, and Eliza Dailey to unpack exactly why Walmart and other retailers are pulling back on primary care delivery, and why the conventional explanation â"healthcare is too complexââ falls short.
Links:
Walmart Health is closing down. Here's what you need to know.Another one bites the dust: What Walmart's retreat from healthcare means for providers5 trends (re)shaping site-of-care shifts6 insights on consumer preferences in healthcareHow Amazon, CVS, Walmart, and more are impacting provider payOur Disruption playlistEp. 130: Healthcare disruptors: Don't discount retailers[July 25] Understand your customer: Medical groups 101
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
Radio Advisory first started production in April 2020 to deliver timely, critical messages to healthcare professionals navigating the early days of the Covid-19 pandemic.
Four years, 200+ episodes, and one million downloads later, Radio Advisory continues to bring insightful conversations and valuable insights to listeners passionate about driving positive change in healthcare.
To celebrate our millionth download, host Rachel (Rae) Woods and the Radio Advisory production team revisit some of their favorite episodes over the last four years, recollect the lessons learned, and reflect on how the healthcare industry has evolved alongside us.
We owe this milestone to you, our listeners. Your support and engagement have fueled and enriched our episodes, and we look forward to bringing you many more insightful conversations. Thank you!
Links:
Ep. 2: How COVID-19 is transforming telehealth now and in the futureEp. 35: Zeke Emanuel on the path to a vaccine (and why it's much harder than you think)Ep. 69: CEO Warner Thomas on 20 years of digital innovation at Ochsner HealthEp. 159: Ozempic, Wegovy, and our questions on weight management drugs3 paths to the future of obesity care (and how to get there)5 catalysts that will impact the future of weight management drugsWhat the headlines get wrong about weight-management medicationsHow Cone Health added ATTR-CM screening to an existing care pathway: A TAVR example
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
Generative AI is one of the most widely discussed topics in the industry today. There is continued excitement, mounting anxiety, and dozens of questions for health leaders to answer. While the healthcare industry has been working tirelessly to adapt to the almost unbelievable rate of change, many organizations struggle with how to ethically implement and scale Artificial Intelligence.
This week, host Rachel (Rae) Woods invites Duke University Health System's Chief Information Officer, Dr. Eric Poon, to discuss how Duke has approached ethical implementation of AIâand how their efforts started long before ChatGPT existed. Throughout the conversation, they discuss the early challenges Duke faced, offer tactical guidance for successful implementation, and explain why proper governance is critical to ethical AI adoption.
Links:
Duke Health | Connect with your health care at Duke HealthThe best AI strategy isn't about AIAI in healthcare: Insights from 10 C-suite executivesEp. 180: Tom Lawry on why AI has a PR problemUsing simplified clinical criteria to screen more patients for ATTR-CM
Learn about Advisory Board Fellowship
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
The healthcare industry has been rocked by the pandemic and thrown headfirst into a new era of technological and therapeutic revolution. Yet, in the midst of all this change and uncertainty, healthcare leaders are expected not just to survive, but actually drive value for their organizations, patients, and communities. The problem is, âdriving valueâ is not only complex, but itâs also ambiguous. Leaders who talk about value across the industry may not even be talking about the same thing. So, how should the industry think about driving value and what does it take to get this right?
In this episode, live from Advisory Boardâs 2024 Value Summit, host Abby Burns invites Stacey Richter, healthcare entrepreneur, co-president of Aventria Health Group, and host of the Relentless Health Value podcast, to break down what âvalueâ in healthcare actually means, where organizations go wrong, and how we can work to improve value across the industry.
Links:
Raising the Value Bar Virtual SummitOur Value-Based Care playlistEP358: How Health Insurance Plan Design Can Lead to Patients Sacrificing Needed Care, Their Mental Health, and (Sometimes) Buying Groceries, With Wayne Jenkins, MD | Relentless Health ValueâąEP391: Lessons for Private Equity and Others Trying to Do Right by PCPs and Their Patients, With Scott Conard, MD | Relentless Health ValueâąEP427: How Do Digital Health Vendors Deliver Patient Outcomes and Experiences? With Rik Renard | Relentless Health ValueâąEP432: The Knifepoint Intersection of Margin and Mission and the Peril of Cutting Clinical âWaste,â With Kate Wolin, ScD | Relentless Health ValueâąThe challenges with migraine care â and what health systems can do about it
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
The rise of generative AI has impacted healthcare in many ways â one of which is that itâs pushing Big Tech toward becoming not just a relevant, but a central player in the industry. And when weâre talking Big Tech, we have to include Google. Googleâs activity in healthcare has been turbulent since it entered the space nearly two decades ago, but itâs impossible to deny the significance of the contributions itâs made to the industry.
Now with the rapid growth of genAI, Google is refining its healthcare strategy to drive maximum impact in the areas itâs best positioned to â places like consumer, therapeutics, diagnostics, and more.
At the forefront of this work is Dr. Karen DeSalvo, Googleâs Chief Health Officer. This week, guest host Eric Larsen, President Emeritus of Advisory Board and President of Towerbrook Advisors sits down with Dr. DeSalvo to unpack the seemingly boundless opportunities of generative AI to evolve healthcare and the uniqueâand scopedârole Google is playing in helping advance that evolution.
Links:
Lessons from the C-suiteAI in healthcare: Insights from 10 C-suite executivesEp. 197: Lessons from the C-Suite: Demystifying generative AI with Dr. John Halamka, President of Mayo Clinic PlatformEp. 185: AI adoption: why you can't afford to "wait and see"Ep. 180: Tom Lawry on why AI has a PR problemThe chronic condition we should be talking about: Challenges and opportunities in migraine care
Learn about Advisory Board Fellowship
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
So far in our series on bespoke care and innovation, weâve delved into the future of cancer care and the opportunities for equity in precision medicine. But we canât conclude our series without talking about one of the most exciting developments in the field: cell and gene therapies. Weâve talked about these therapies on the pod beforeâbut like everyone else, weâve primarily focused on the payment side of the equation and looked at how purchasers and pharma can work together to ensure patient access. These conversations miss the voice of a key stakeholder: providers.
What is the role of the provider organizations in realizing the value of cell and gene therapies? To answer that question, in the final episode of our series leading up to Advisory Boardâs Clinical Innovation Summit: Revolutions in Specialty Care, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to unpack how providers are grappling with how to get these life-changing treatments to those that need them.
Links:
Ep. 210: How you approach precision medicine mattersâfor some patients more than othersEp. 209: Predicting what oncology will look like in 20304 things leaders need to know about high-cost drugs3 takeaways on why primary care is key to migraine management
Register for the Revolutions in Specialty Care Summit
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
It's no secret that healthcare is becoming more and more personalized â or âbespokeâ â as increasingly sophisticated diagnostics and therapeutics continue to explode into the market. This vast pipeline is redefining the industry in several waysâbut there is real risk associated if the stakeholders responsible for developing, delivering, and paying for these innovations arenât baking health equity into their business models.
Last week, in the first episode of our run up to the Advisory Board Clinical Innovation Summit: Revolutions in Specialty Care, we discussed Advisory Boardâs prediction for the future of oncology. This week, host Rachel (Rae) Woods invites Advisory Board experts Amanda Okaka and Fanta Cherif to break down the health equity conundrum presented by precision medicine: Will precision medicine reduce health disparities, or exacerbate them? The answer depends on the actionsâbig and smallâof industry leaders.
Links:
Register for the Revolutions in Specialty Care SummitHow precision medicine can help us move from race-based to race-conscious medicineEp. 209: Predicting what oncology will look like in 2030Ep. 204: Unveiling "Bespoke Care": Healthcare's tailored futureBespoke care, part 1: What it is and how itâs transforming care deliveryRegister for the Clinical Innovation Summit
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
There has been a lot of change in the oncology space in the last few years. These changes have brought new pressures, like workforce strain, increased competition, rising spend, and more. While many leaders are worried about the "right now," it is crucial to consider how you can best position yourself for the future of cancer care.
That's why, in this episode, host Rachel (Rae) Woods invites Advisory Board specialty care experts Lindsey Paul and Julia Elder to discuss why preparing for the future means making changes today. Throughout the conversation, they discuss how current pressures are changing the field of oncology and four ways cancer care will change by 2030.
Links:
4 predictions for cancer care in 20303 strategies to leverage oncology pharmacists and improve cancer care5 strategies to deploy (and empower) APPs in cancer careEp. 203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes.Ep. 202: Value series: Why CenterWell (and Humana) is going all in on senior careRegister for the Clinical Innovation Summit
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
According to economist Jim Rebitzer and healthcare consultant Bob Rebitzer, the healthcare industry has failed in achieving what many other sectors have accomplished â improving products, while simultaneously reducing costs over time.
In this episode, recorded live at The Players 2024 Championship, host Rachel (Rae) Woods invited Jim and Bob to discuss the central premise of their book, Why Not Better and Cheaper? They discussed the root causes of this challenge â including incentives, prevailing professional and social norms, and competition â that the industry must confront to deliver better and cheaper healthcare.
Links:
Learn more about the Rebitzer brothers and their new book, Why Not Better and Cheaper?Our Financial Impact playlistThis spring Radio Advisory is celebrating four years of production. Thank you for listening!Truly personalized care is possible. Here's how to make it a reality.Learn about Advisory Board On-Demand Courses
Learn about Advisory Board Fellowship
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
-
Radio Advisory has commemorated Nurses Week every year since we started production in April 2020. A lot has changed since the early days of the pandemic, but the reality is that weâre still grappling with a workforce crisis defined by rising burnout, turnover, and shortages. Celebrating nurses just one week out of the year will not suffice in addressing these complex issues.
In this episode, host Rachel (Rae) Woods sits down with Advisory Board nursing experts Monica Westhead, Allyson Paiewonsky, and Ali Knight to discuss why the industry needs to pivot towards more sustainable strategies for their care teams, what leaders should be thinking about when training and supporting nurses, and why "top-of-license care" is an incomplete solution.
Links:
[Webinar] How to cultivate resilient and adaptive nurse leaders4 ways to retain early career nurses3 underlying causes of nurse recruitment and retention challengesA detailed look at the top 2 models for virtual nursing care3 ways AI can help nursesAI nurses? Inside Nvidia, Hippocratic AI's new partnershipOur Clinical Workforce playlistEp. 205: Live from ViVE 2024: Four leaders on how technology is redefining clinical workEp. 162: Addressing the workforce crisis: Insights from University Hospitals' leadersEp. 135: Henry Ford Health on nursing shortages and the real supply chain issue6 advantages to matching patients with compatible clinicians (sponsored by Optum Match)
Learn about Advisory Board Fellowship
[Webinar, May 14] Bespoke care, part 1: What it is and how itâs transforming care delivery
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
- Mostrar más
![[Encore] What the industry is (still) getting wrong about value-based care](https://is5-ssl.mzstatic.com/image/thumb/Podcasts116/v4/91/2a/42/912a42a3-be1a-14db-1638-3335cc1dd6ab/mza_9395932618523464993.jpg/80x80bb.jpg)